1. Home
  2. RCKT vs SIMO Comparison

RCKT vs SIMO Comparison

Compare RCKT & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • SIMO
  • Stock Information
  • Founded
  • RCKT 1999
  • SIMO 1995
  • Country
  • RCKT United States
  • SIMO Hong Kong
  • Employees
  • RCKT N/A
  • SIMO N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • RCKT Health Care
  • SIMO Technology
  • Exchange
  • RCKT Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • RCKT 264.0M
  • SIMO 2.4B
  • IPO Year
  • RCKT N/A
  • SIMO 2005
  • Fundamental
  • Price
  • RCKT $3.02
  • SIMO $72.96
  • Analyst Decision
  • RCKT Buy
  • SIMO Strong Buy
  • Analyst Count
  • RCKT 13
  • SIMO 8
  • Target Price
  • RCKT $18.50
  • SIMO $80.63
  • AVG Volume (30 Days)
  • RCKT 4.0M
  • SIMO 323.3K
  • Earning Date
  • RCKT 08-04-2025
  • SIMO 07-30-2025
  • Dividend Yield
  • RCKT N/A
  • SIMO 2.76%
  • EPS Growth
  • RCKT N/A
  • SIMO 59.19
  • EPS
  • RCKT N/A
  • SIMO 2.80
  • Revenue
  • RCKT N/A
  • SIMO $780,733,000.00
  • Revenue This Year
  • RCKT N/A
  • SIMO $2.23
  • Revenue Next Year
  • RCKT N/A
  • SIMO $13.23
  • P/E Ratio
  • RCKT N/A
  • SIMO $26.39
  • Revenue Growth
  • RCKT N/A
  • SIMO 10.84
  • 52 Week Low
  • RCKT $2.19
  • SIMO $37.21
  • 52 Week High
  • RCKT $26.98
  • SIMO $85.00
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 45.25
  • SIMO 61.15
  • Support Level
  • RCKT $2.76
  • SIMO $72.26
  • Resistance Level
  • RCKT $2.96
  • SIMO $75.52
  • Average True Range (ATR)
  • RCKT 0.20
  • SIMO 2.07
  • MACD
  • RCKT 0.16
  • SIMO -0.44
  • Stochastic Oscillator
  • RCKT 88.57
  • SIMO 52.26

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: